Quest Diagnostics’ (DGX) Haystack Oncology Forges New MRD Deal
ZacksQuest Diagnostics’ (DGX) subsidiary, Haystack Oncology, partners on the use of its MRD technology.
Quest Diagnostics’ (DGX) subsidiary, Haystack Oncology, partners on the use of its MRD technology.